Literature DB >> 14580307

Decreased synthetic capacity underlies the age-associated decline in glutathione content in Fisher 344 rats.

Rui-Ming Liu1, Dale A Dickinson.   

Abstract

Although it is well documented that the concentration of glutathione (GSH), the most abundant intracellular free thiol and an important antioxidant, declines with age in many tissues of different animal species, the underlying mechanism is not well understood. In a previous study, we showed that the expression of the glutamate cysteine ligase genes was down-regulated with age, accompanied by a decline in GSH content in the liver, kidney, and lung of Fisher 344 rats. The aim of this study was to examine the age-associated changes in the activities of three other enzymes, which also play important roles in GSH biosynthesis, to further explore the mechanism underlying the age-associated decline in GSH content in Fisher 344 rats. The results showed for the first time that the activity and gene expression of glutathione synthase, which catalyzes the second reaction in de novo GSH synthesis, were also decreased with increased age in the lung and kidney, but not in the liver or heart. No age-associated change in the activity of either gamma-glutamyltranspeptidase or glutathione reductase was observed in any of the organs examined. The results further indicate that decreased GSH synthetic capacity is responsible for the age-associated decline in GSH content in Fisher 344 rats.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14580307     DOI: 10.1089/152308603770310176

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  8 in total

1.  Arsenic responsive microRNAs in vivo and their potential involvement in arsenic-induced oxidative stress.

Authors:  Xuefeng Ren; Daniel P Gaile; Zhihong Gong; Wenting Qiu; Yichen Ge; Chuanwu Zhang; Chenping Huang; Hongtao Yan; James R Olson; Terrance J Kavanagh; Hongmei Wu
Journal:  Toxicol Appl Pharmacol       Date:  2015-01-24       Impact factor: 4.219

2.  Therapeutic potential and anti-amyloidosis mechanisms of tert-butylhydroquinone for Alzheimer's disease.

Authors:  Hasina Akhter; Ashwini Katre; Ling Li; Xuebo Liu; Rui-Ming Liu
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

3.  Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers.

Authors:  Jason Allen; Ryan D Bradley
Journal:  J Altern Complement Med       Date:  2011-09       Impact factor: 2.579

4.  Transforming growth factor β suppresses glutamate-cysteine ligase gene expression and induces oxidative stress in a lung fibrosis model.

Authors:  Rui-Ming Liu; Praveen Kumar Vayalil; Carol Ballinger; Dale A Dickinson; Wen-Tan Huang; Suqing Wang; Terrance J Kavanagh; Qiana L Matthews; Edward M Postlethwait
Journal:  Free Radic Biol Med       Date:  2012-05-23       Impact factor: 7.376

5.  Low dose monocrotaline causes a selective pulmonary vascular lesion in male and female pneumonectomized rats.

Authors:  Daniel J Lachant; David F Meoli; Deborah Haight; Jason A Lyons; Robert F Swarthout; R James White
Journal:  Exp Lung Res       Date:  2018-01-30       Impact factor: 2.459

6.  Age-related changes in antioxidant enzymes related to hydrogen peroxide metabolism in rat inner ear.

Authors:  Donald Coling; Shan Chen; Lai-Har Chi; Samson Jamesdaniel; Donald Henderson
Journal:  Neurosci Lett       Date:  2009-08-11       Impact factor: 3.046

7.  The Precursor to Glutathione (GSH), γ-Glutamylcysteine (GGC), Can Ameliorate Oxidative Damage and Neuroinflammation Induced by Aβ40 Oligomers in Human Astrocytes.

Authors:  Nady Braidy; Martin Zarka; Bat-Erdene Jugder; Jeffrey Welch; Tharusha Jayasena; Daniel K Y Chan; Perminder Sachdev; Wallace Bridge
Journal:  Front Aging Neurosci       Date:  2019-08-08       Impact factor: 5.750

Review 8.  Metabolic reprogramming: a bridge between aging and tumorigenesis.

Authors:  Stanislav Drapela; Didem Ilter; Ana P Gomes
Journal:  Mol Oncol       Date:  2022-06-19       Impact factor: 7.449

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.